Peter Jüni

Peter is a Professor of Medicine and Clinical Trials at the Nuffield Department of Population Health of the University of Oxford. He is a graduate of the Faculty of Medicine at the University of Bern in Switzerland, completed his training in internal medicine at various hospitals in Switzerland, and was a Senior Research Fellow at the Department of Social Medicine at the University of Bristol, UK. Prior to joining the University of Oxford, Peter was the Director of the Applied Health Research Centre at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital and a Professor of Medicine and Epidemiology at the University of Toronto (Ontario, Canada). Peter held previous appointments as Director of the Institute of Primary Health Care and Professor of Primary Care and Clinical Epidemiology at the University of Bern (Switzerland), Director of the Institute of Social and Preventive Medicine and Founding Director of the University of Bern’s clinical trials unit. Between 2020 and 2022, he served as Scientific Director of the Ontario COVID-19 Science Advisory Table, advising Ontario’s government and informing the public. Peter’s work has focused on methodological issues and on clinical trials and meta-analyses on the management of cardiovascular and musculoskeletal disorders. A Fellow of the European Society of Cardiology, he has had leading roles in major cardiovascular trials, including SIRTAX, FAME 2, GLOBAL LEADERS and MATRIX, and co-authored several European guidelines on the management of cardiovascular disease and diabetes. He contributed to more than 500 papers and has been recognized as a highly cited researcher by the Institute for Scientific Information since 2015.